Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about disclosure

22 Mar 2024 Evaluate
Zydus Lifesciences has informed that it enclosed disclosure in prescribed Form C under regulation 7(2) of Insider Trading received from Vishal J. Gor, Sr. Vice President -Corporate Finance of the Company with respect to sale of 862 equity shares of Re 1 each in the open market.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1915.10
Dr. Reddys Labs. 1369.00
Cipla 1410.95
Lupin 1995.00
Zydus Lifesciences 1200.00
View more..